Llach and colleagues examined responses to endogenous PTH by infusing the chelating agent ethylenediaminetetraacetic acid (EDTA); in comparison to control subjects, patients with mild CKD responded to EDTA with more severe hypocalcemia, much higher [PTH], and a more delayed recovery of [Ca]s [45]. The gene discussed is PTH; the disease is Hypocalcemia.